Hong Kong-listed pharmaceutical company, Luye Pharma (HKG:2186) filed to list $50 million worth of 5.85% convertible bonds due in 2025, on the Singapore bourse, according to a filing with the Singapore Exchange on Friday.
The bonds will be listed and quoted in the Bonds Market on Nov. 26, the filing added.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments